Zhongchao (NASDAQ:ZCMD) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of Zhongchao (NASDAQ:ZCMDFree Report) to a sell rating in a research note published on Saturday morning.

Separately, Weiss Ratings raised shares of Zhongchao from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Monday, June 8th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, Zhongchao presently has a consensus rating of “Sell”.

Check Out Our Latest Analysis on Zhongchao

Zhongchao Stock Down 12.1%

Shares of Zhongchao stock opened at $1.23 on Friday. The firm’s 50-day moving average price is $22.56 and its two-hundred day moving average price is $146.19. Zhongchao has a 1-year low of $0.80 and a 1-year high of $967.20.

Zhongchao Company Profile

(Get Free Report)

Zhongchao Inc provides healthcare information, education, and training services in the People's Republic of China. The company offers online and onsite health information services, healthcare education programs, and healthcare training products, including clinical practice training, open classes of popular medical topics, interactive case studies, academic conference and workshops, continuing education courses, and articles and short videos with educational healthcare content. It also provides customized medical courses and medical training services; and patient management services through online platform under the Zhongxun brand.

Further Reading

Receive News & Ratings for Zhongchao Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zhongchao and related companies with MarketBeat.com's FREE daily email newsletter.